Three values drive everything we do at Target ALS.

⏱️ Impatient Optimism
🤝 Radical Collaboration
⚡ Deliberate Disruption

With these values guiding us, we're moving closer to our ultimate goal: a world where #EveryoneLives. Learn more about our work: targetals.org/our-mission.

Breaking news! We're thrilled to celebrate the enactment of the ACT for ALS Reauthorization Act of 2026 alongside our peer ALS organizations. We credit this success to the powerful voices of the ALS community. Thank you to everyone who championed this effort.

We have joined The Research Acceleration and Innovation Network (TRAIN), led by @fastercures of the @MilkenInstitute. TRAIN brings together 180+ nonprofit research organizations committed to a more strategic approach to advancing #research and driving progress for patients.

Team Target ALS crushed the #TCSNYCMarathon! We’re so proud of our runners, who took on 26.2 miles to forge the path to a world where #EveryoneLives. The team has raised over $114,000 for critical #ALS research. Show your support by making a gift at targetals.org/new-york-city-…

Last May, Ashlin Conroy’s best friend Tiffany was diagnosed with #ALS at just 30 years old. This Sunday, Ashlin is taking on the #NYCMarathon to raise funds for the research that gives hope to the ALS community. Support her run at support.targetals.org/site/TR/DIYFun…

The Global Natural History Study is the most comprehensive and inclusive study in #ALSResearch. To find effective treatments for everyone with #ALS, we need a better understanding of the disease. Learn more about participation by registering your interest: targetals.org/rsvp-for-als-s…

Target ALS team members Laura Dugom and Marina Selenica are attending the 2026 Annual NEALS Meeting. We're looking forward to sharing our research and connecting with the community. Stop by the poster session to learn more about our work. #ALS #ALSResearch #NEALS

Data powers discovery. The newest update to the Target ALS Data Engine expands two growing collections. Any ALS researcher across the globe can access these datasets. Sign up and start mining today: dataengine.targetals.org #ALS #Data #AI #ALSResearch

Conor John Regan is taking on the #NYCMarathon on Team Target ALS. And with every step of those 26.2 miles, he’ll be honoring his dad, John, who passed away in 2014 after a courageous battle with ALS. Support Conor’s run at ow.ly/gkCU5100GMG

The path to effective treatments for #ALS begins with you. When you #fundraise for Target ALS, you’ll help accelerate the pace of research and bring us closer to a world where #EveryoneLives. Start your fundraiser today: targetals.org/fundraise-for-…

We're proud to announce that three consortia have been selected for awards through our Biomarker Consortia Program, which supports collaborative research on #biomarkers for patient stratification and disease progression in #ALS. Learn more: targetals.org/news/announcin…

After losing her mom to ALS and having two friends live with the disease, Kristine Shine is running in the #NYCMarathon to support research that will extend life with ALS and give people more time.

Support Kristine’s run: ow.ly/qwVC50ZYzz1

#ALS #ALSAwareness #Fundraiser

Last October, Kristen Alfano’s life changed unexpectedly: her stepdad was diagnosed with ALS.
Kristen refuses to let her grief consume her. She’s channeling it into something meaningful by running the #NYCMarathon on Team Target ALS. Support her run at ow.ly/TT3850ZXolV

We are saddened to share the passing of Pat Dolan.

After receiving his ALS diagnosis in 2016, Pat launched GeoALS to improve care and accelerate research. His compassion and resilience led to incredible resources that will continue to improve the lives of those with ALS.

Last week, we launched our ALS Resource Center, a dedicated space for the #ALSCommunity and those interested in the fight against #ALS to learn more about the disease and better understand what’s happening in #ALSResearch.

Check it out today: ow.ly/cfs350ZVxpg

We are thrilled to announce that the first participant in Malaysia has been enrolled in the Target ALS Global Natural History Study (GNHS)!

To build a world where everyone lives, we have to study everyone. Learn more about the GNHS & how to participate targetals.org/gnhs

This November, Dr. Nazem Atassi, an ALS physician and drug developer, will take on the 2026 #NYCMarathon with Team Target ALS, running to raise awareness and support for a community that has shaped his life's work.

Join Nazem in supporting #ALSResearch: ow.ly/SPkO50ZTHmf

We understand that an ALS diagnosis often comes with more questions than answers.

That's why we created the ALS Resource Center: a hub of expert-informed guidance on navigating ALS, understanding clinical trials, and learning about research.

Explore: targetals.org/als-resource-c…

The All India Institute of Medical Sciences (AIIMS) in New Delhi and the National Institute of Mental Health and Neuro Sciences (NIMHANS) in Bangalore are now part of our Global Natural History Study (GNHS)—adding to the most comprehensive and diverse #ALSResearch effort.

In case you missed it, a recording of our webinar, "Understanding Clinical Trials: A Guide for the ALS Community," is available to watch.

Learn how ALS drugs move from the lab to #clinicaltrials, what makes a drug ready for a clinical trial, and more. ow.ly/HrHB50ZSs5Q